Singapore, June 3 -- To accelerate clinical trial activation and execution, enhance research quality, and strengthen international competitiveness, Taiwan's Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH) has officially signed a Memorandum of Understanding (MoU) with AbbVie, a globally renowned biopharmaceutical company.

Through the implementation of the "SC Helper Programme," this collaboration further deepens the strategic partnership between the two parties and sets a new benchmark for efficient clinical research collaboration.

A key highlight of this partnership is KMUH's achievement in being the first among global research centers to enroll a patient in a clinical trial for metastatic colorectal cancer.

Backed by co...